News

The reserarchers found that a weekly dose of semaglutide was effective at treating Metabolic Dysfunction-Associated ...
Results from studies at Virginia Commonwealth University (VCU) show that an Aramchol and Bayer's Regorafenib drug combination significantly reduced hepatic tumor ...
Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related care to be ...
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological therapeutics, announced today that ...
The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
I t’s hard to overstate just how revolutionary the development of medications like Ozempic and Wegovy has been for managing ...
A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...
Semaglutide, the blockbuster drug better known by brand names like Ozempic and Wegovy, has now shown significant promise in ...
Weight-loss surgeries for adolescents increased 15% in the U.S. between 2021 and 2023, even as the Food and Drug ...
We want you to take advantage of everything Clinical Advisor has to offer. To view unlimited content, log in or register for free.
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...